Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Treilleux

Showing results (41-50 of 186) with videos related to

Pageof 19
Sort By:
Cell Death & Disease|June 30, 2023
Nrh L11R single nucleotide polymorphism, a new prediction biomarker in breast cancer, impacts endoplasmic reticulum-dependent Ca<sup>2+</sup> traffic and response to neoadjuvant chemotherapyMinh Quang Duong, Rudy Gadet, Isabelle Treilleux, et al.
International Journal of Cancer|May 18, 2004
Breast carcinoma cells promote the differentiation of CD34+ progenitors towards 2 different subpopulations of dendritic cells with CD1a(high)CD86(-)Langerin- and CD1a(+)CD86(+)Langerin+ phenotypesMarie Cécile Thomachot, Nathalie Bendriss-Vermare, Catherine Massacrier, et al.
Cell Death & Disease|February 28, 2023
Notch3 regulates Mybl2 via HeyL to limit proliferation and tumor initiation in breast cancerSonia Brahim, Ana-Maria Negulescu, Clara Geneste, et al.
Gynecologic Oncology|June 29, 2010
Management of rare ovarian cancers: the experience of the French website "Observatory for rare malignant tumours of the ovaries" by the GINECO group: interim analysis of the first 100 patientsIsabelle Ray-Coquard, Béatrice Weber, Jean Pierre Lotz, et al.
Oncogene|January 30, 2019
The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancerAli Choucair, Thuy Ha Pham, Soleilmane Omarjee, et al.
Clinical Breast Cancer|May 13, 2009
Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case seriesSana Intidhar Labidi, Thomas Bachelot, Isabelle Ray-Coquard, et al.
Breast Cancer Research : BCR|May 21, 2020
ERα-36 regulates progesterone receptor activity in breast cancerHenri-Philippe Konan, Loay Kassem, Soleilmane Omarjee, et al.
American Journal of Surgery|April 1, 2014
Management of patients diagnosed with atypical ductal hyperplasia by vacuum-assisted core biopsy: a prospective assessment of the guidelines used at our institutionAlizée Caplain, Youenn Drouet, Mathilde Peyron, et al.
Carcinogenesis|April 1, 2015
17β-estradiol inhibits spreading of metastatic cells from granulosa cell tumors through a non-genomic mechanism involving GPER1Charlotte M François, Richard Wargnier, Florence Petit, et al.
International Journal of Cancer|October 6, 2018
LKB1 regulates PRMT5 activity in breast cancerHanine Lattouf, Loay Kassem, Julien Jacquemetton, et al.
Pageof 19

Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
Cell Death & Disease|June 30, 2023
Nrh L11R single nucleotide polymorphism, a new prediction biomarker in breast cancer, impacts endoplasmic reticulum-dependent Ca<sup>2+</sup> traffic and response to neoadjuvant chemotherapyMinh Quang Duong, Rudy Gadet, Isabelle Treilleux, et al.
International Journal of Cancer|May 18, 2004
Breast carcinoma cells promote the differentiation of CD34+ progenitors towards 2 different subpopulations of dendritic cells with CD1a(high)CD86(-)Langerin- and CD1a(+)CD86(+)Langerin+ phenotypesMarie Cécile Thomachot, Nathalie Bendriss-Vermare, Catherine Massacrier, et al.
Cell Death & Disease|February 28, 2023
Notch3 regulates Mybl2 via HeyL to limit proliferation and tumor initiation in breast cancerSonia Brahim, Ana-Maria Negulescu, Clara Geneste, et al.
Gynecologic Oncology|June 29, 2010
Management of rare ovarian cancers: the experience of the French website "Observatory for rare malignant tumours of the ovaries" by the GINECO group: interim analysis of the first 100 patientsIsabelle Ray-Coquard, Béatrice Weber, Jean Pierre Lotz, et al.
Oncogene|January 30, 2019
The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancerAli Choucair, Thuy Ha Pham, Soleilmane Omarjee, et al.
Clinical Breast Cancer|May 13, 2009
Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case seriesSana Intidhar Labidi, Thomas Bachelot, Isabelle Ray-Coquard, et al.
Breast Cancer Research : BCR|May 21, 2020
ERα-36 regulates progesterone receptor activity in breast cancerHenri-Philippe Konan, Loay Kassem, Soleilmane Omarjee, et al.
American Journal of Surgery|April 1, 2014
Management of patients diagnosed with atypical ductal hyperplasia by vacuum-assisted core biopsy: a prospective assessment of the guidelines used at our institutionAlizée Caplain, Youenn Drouet, Mathilde Peyron, et al.
Carcinogenesis|April 1, 2015
17β-estradiol inhibits spreading of metastatic cells from granulosa cell tumors through a non-genomic mechanism involving GPER1Charlotte M François, Richard Wargnier, Florence Petit, et al.
International Journal of Cancer|October 6, 2018
LKB1 regulates PRMT5 activity in breast cancerHanine Lattouf, Loay Kassem, Julien Jacquemetton, et al.
Pageof 19